Exclusive: Dicerna CEO Talks Products, Partnerships And Stock Performance
February 15, 2017 at 13:54 PM EST
Benzinga recently had the chance to chat with Dicerna Pharmaceuticals Inc (NASDAQ: DRNA)’s CEO Douglas M. Fambrough, Ph.D., who ...